Call for Abstract

17th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, will be organized around the theme “Understanding What’s Important in Pharmaceutics and Novel drug delivery systems”

Pharmaceutica 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharmaceutica 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Bio Pharmaceutics conferences plays an important role in drug discovery like drug disposition, Innovations in clinical development, Pharmaceutical technology, Pharmaceutics and drug delivery, Drug design, Targeted drug, gene delivery,  Sustained drug delivery system, Routes of administration, Fundamental drug development.

For more information visit: Pharmaceutical Conferences

 

  • Track 1-1Biopharmaceutics and drug disposition
  • Track 1-2Pharmaceutical technology
  • Track 1-3Innovations in clinical development

Pharmaceutical Chemistry the study of drug design to optimize pharmacokinetics and pharmacodynamics, and synthesis of new drug molecules (Medicinal Chemistry 2018). Pharmaceutical Chemistry is a branch of chemistry that deals with the chemical, biochemical and pharmacological aspects of drugs. It includes synthesis/isolation, identification, structural elucidation, structural modification, structural activity relationship (SAR) studies, study of the chemical characteristics, biochemical changes after drug administration and their pharmacological effects as well as analysis of drugs. In more simple words it is more broader than medicinal chemistry in its application also in the fields of analysis, identification, as well as, structural elucidation of drugs

For more information visit: Pharmaceutical Conferences

 

  • Track 2-1Drug discovery
  • Track 2-2Protein structure prediction and molecular simulation
  • Track 2-3Biochemistry
  • Track 2-4Exploratory development
  • Track 2-5Phytotherapy & complementary medicine
  • Track 2-6Protein structure prediction and molecular simulation

Drug Design Conferences, often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modeling techniques. This type of modeling is sometimes referred to as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the biomolecular target is known as structure-based drug design. In addition to small molecules, biopharmaceuticals and especially therapeutic antibodies are an increasingly important class of drugs and computational methods for improving the affinity, selectivity, and stability of this protein-based therapeutics have also been developed

For more information visit: Pharmaceutical Conferences

 

  • Track 3-1Drug targeting strategies
  • Track 3-2Factors influencing drug targeting
  • Track 3-3Advances in drug targeting components
  • Track 3-4Recent approaches to drug targeting
  • Track 3-5Rational drug design
  • Track 3-6Computer aided drug design
  • Track 3-7Drug design theory

Pharmacokinetics is currently defined as the study of the time course of drug absorption, distribution, metabolism, and excretion. Clinical pharmacokinetics is the application of pharmacokinetic principles to the safe and effective therapeutic management of drugs in an individual patient. Primary goals of clinical pharmacokinetics include enhancing efficacy and decreasing toxicity of a patient’s drug therapy. The development of strong correlations between drug concentrations and their pharmacologic responses has enabled clinicians to apply pharmacokinetic principles to actual patient situations.

Pharmacodynamics refers to the relationship between drug concentration at the site of action and the resulting effect, including the time course and intensity of therapeutic and adverse effects. The effect of a drug present at the site of action is determined by that drug’s binding with a receptor. Receptors may be present on neurons in the central nervous system (i.e., opiate receptors) to depress pain sensation, on cardiac muscle to affect the intensity of contraction, or even within bacteria to disrupt maintenance of the bacterial cell wall.

For more information visit: Pharmaceutical Conferences

 

  • Track 4-1Pharmacokinetic parameters
  • Track 4-2Pharmacodynamic parameters
  • Track 4-3Absorption of drugs
  • Track 4-4Distribution of drugs
  • Track 4-5Biotransformation/metabolism
  • Track 4-6Excretion of drugs
  • Track 4-7Pharmacodynamics

Pharmaceutical formulation 2018, in pharmaceutics, is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form.

For more information visit: Pharmaceutical Conferences

 

  • Track 5-1Preformulation in drug discovery
  • Track 5-2Preformulation in drug development
  • Track 5-3Drug formulation considerations
  • Track 5-4Formulation types
  • Track 5-5Enteral formulations
  • Track 5-6Parenteral formulations
  • Track 5-7Topical formulations

Drug manufacturing is the process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be broken down into a series of unit operations, such as milling, granulation, coating, tablet pressing, and others

For more information visit: Pharmaceutical Conferences

 

  • Track 6-1Formulation and pre-formulation development
  • Track 6-2Powder blending
  • Track 6-3Milling
  • Track 6-4Milling
  • Track 6-5Milling
  • Track 6-6Granulation
  • Track 6-7Hot melt extrusion

Sometimes called, molecular manufacturing is a branch of engineering that deals with the design and manufacture of extremely small electronic circuits and mechanical devices built at the molecular level of matter. Nanotechnology is also being applied to or developed for application to a variety of industrial and purification processes. Purification and environmental clean-up applications include the desalination of water, water filtration, wastewater treatment, groundwater treatment, and other Nano remediation.

For more information visit: Pharmaceutical Conferences

 

  • Track 7-1Nanobiomaterials and biopharmaceuticals
  • Track 7-2Nano-drugs
  • Track 7-3Nanotechnology and clinical applications
  • Track 7-4Nanotechnology in medicine and drug delivery imaging
  • Track 7-5Nanotechnology in targeted drug delivery
  • Track 7-6Nanotechnology in cancer research
  • Track 7-7Pharmaceutical engineering
  • Track 7-8Bionanotechnology and biomems
  • Track 7-9Nano-mechanisms for molecular systems

Drug delivery 2018 is the process of administering the drug or pharmaceutical product, in order to achieve desired therapeutic effect. The method by which drug delivered is important, as it has significant effect on its efficacy. Novel drug delivery system conferences involves various approaches like medical devices or drug-device combination products. Novel drug delivery system (NDDS 2019) involves combining polymer science, pharmaceutics and molecular biology. Novel drug delivery systems are designed based on physical and biochemical mechanisms. Physical mechanism or controlled drug delivery system includes dissolution, osmosis, erosion and diffusion. Biochemical mechanism includes gene therapy, liposomes, nanoparticles, monoclonal antibodies. NDDS drugs are designed to target the site specific region, in order to achieve desired therapeutic effect, thereby reducing the side or toxic effects. Various drug delivery and drug targeted systems are developed, in order to minimize drug degradation, drug adverse effect, and in order to increase the drug bioavailability (amount of drug available at site targeted region). Site specific drug delivery may be either active or passive process.

For more information visit: Pharmaceutical Conferences

 

 

  • Track 8-1Micelles
  • Track 8-2Microspheres
  • Track 8-3Erythrocytes
  • Track 8-4Phonophoresis
  • Track 8-5Iontophoresis
  • Track 8-6Fast dissolving tablets (FDT)
  • Track 8-7Hydrogels
  • Track 8-8Nano particles
  • Track 8-9Dendrimers
  • Track 8-10Liposomes
  • Track 8-11Micelles
  • Track 8-12Magnetic microparticles

Smart drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others. This means of delivery is largely founded on nanomedicine, which plans to employ nanoparticle-mediated drug delivery in order to combat the downfalls of conventional drug delivery. These nanoparticles would be loaded with drugs and targeted to specific parts of the body where there is solely diseased tissue, thereby avoiding interaction with healthy tissue. The goal of a targeted drug delivery systems is to prolong, localize, target and have a protected drug interaction with the diseased tissue. The conventional drug delivery system is the absorption of the drug across a biological membrane, whereas the targeted release system releases the drug in a dosage form. The advantages to the targeted release system is the reduction in the frequency of the dosages taken by the patient, having a more uniform effect of the drug, reduction of drug side-effects, and reduced fluctuation in circulating drug levels. The disadvantage of the system is high cost, which makes productivity more difficult and the reduced ability to adjust the dosages.

For more information visit: Pharmaceutical Conferences

  • Track 9-1Targeted drug delivery
  • Track 9-2Nucleic acid drug delivery systems
  • Track 9-3Antibody targeted-drug conjugates
  • Track 9-4Blood brain barrier delivery
  • Track 9-5Biomems
  • Track 9-62D and 3D printing in drug delivery
  • Track 9-7Self-emulsifying drug delivery systems (SEDDS)
  • Track 9-8Insulin delivery
  • Track 9-9Cancer delivery
  • Track 9-10Pulmonary drug delivery
  • Track 9-11Skin drug delivery
  • Track 9-12Mucosal drug delivery
  • Track 9-13Proteins and surfaces
  • Track 9-14Gene delivery

Nanomedicine is simply the nanotechnology applications in a healthcare setting and the majority of benefits that have already been seen involve the use of nanoparticles to improve the behavior of drug substances and in drug delivery. Today, nanomedicine conferences are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema. Nanomedicine has the potential to develop radical new therapies based on an unprecedented control over both intracellular processes and the extracellular environment at the nanometer scale. To create precise solutions for intricate medical challenges in the area of wound healing, tissue regeneration and mitochondrial disease physical scientists, medical doctors, and industrial partners, work closely in the Radboud Nanomedicine Alliance. The National Nanotechnology Initiative expects new commercial applications in the pharmaceutical industry that may include advanced delivery systems, new therapies, and in vivo imaging.

For more information visit: Pharmaceutical Conferences

 

  • Track 10-1Scope of nanomedicine
  • Track 10-2Novel drugs to nano drugs
  • Track 10-3Nanomedicine for other disease
  • Track 10-4Nanomedicine for gastrointestinal tract (GI) diseases
  • Track 10-5Nanomedicine for CNS
  • Track 10-6Nanomedicine for blood disorders
  • Track 10-7Nanomedicine for lung diseases
  • Track 10-8Nanomedicine for cardiovascular diseases
  • Track 10-9Future aspects of nanomedicine
  • Track 10-10Nanodrugs for herbal medicines and cosmetics

A biomaterial is any substance that has been engineered to interact with biological systems for a medical purpose - either a therapeutic (treat, augment, repair or replace a tissue function of the body) or a diagnostic one. Biomaterials conferences can be derived either from nature or synthesized in the laboratory using a variety of chemical approaches utilizing metallic components, polymers, ceramics or composite materials. They are often used and/or adapted for a medical application, and thus comprise whole or part of a living structure or biomedical device which performs, augments, or replaces a natural function. Such functions may be benign, like being used for a heart valve, or may be bioactive with a more interactive functionality such as hydroxy-apatite coated hip implants. Biomaterials 2019 are also used every day in dental applications, surgery, and drug delivery. For example, a construct with impregnated pharmaceutical products can be placed into the body, which permits the prolonged release of a drug over an extended period of time. A biomaterial may also be an autograft, allograft or xenograft used as a transplant material.

For more information visit: Pharmaceutical Conferences

 

  • Track 11-1Cells and proteins
  • Track 11-2Nanomaterials
  • Track 11-3Biomaterials & therapeutics
  • Track 11-43D printing technologies
  • Track 11-5Biomaterials processing & devices
  • Track 11-6Translational sciences
  • Track 11-7Wound healing
  • Track 11-8Polymers
  • Track 11-9Ceramics and metals
  • Track 11-10Proteins and surfaces
  • Track 11-11Tissue regeneration

Vaccine is a material that induces an immunologically mediated resistance to a disease but not necessarily an infection. Vaccines are generally composed of killed or attenuated organisms or subunits of organisms or DNA encoding antigenic proteins of pathogens. Sub-unit vaccines though exceptionally selective and specific in reacting with antibodies often fail to show such reactions in circumstances such as shifts in epitopic identification center of antibody and are poorly immunogenic. Delivery of antigens from oil-based adjuvants such as Freunds adjuvant lead to a reduction in the number of doses of vaccine to be administered but due to toxicity concerns like inductions of granulomas at the injection site, such adjuvants are not widely used. FDA approved adjuvants for human uses are aluminium hydroxide and aluminium phosphate in the form of alum. Hence, search for safer and potent adjuvants resulted in the formulations of antigen into delivery systems that administer antigen in particulate form rather than solution form.

 

Other reasons driving the development of vaccines as controlled drug delivery systems are as follows:

 

  • Immunization failure with conventional immunization regimen involving prime doses and booster doses, as patients neglect the latter. Vaccines delivery systems on the other hand:
  • Allow for the incorporation of doses of antigens so that booster doses are no longer necessary as antigens are released slowly in a controlled manner.
  • Control the spatial and temporal presentation of antigens to the immune system there by promoting their targeting straight to the immune cells.

For more information visit: Pharmaceutical Conferences

 

  • Track 12-1Cancer vaccines
  • Track 12-2Influenza vaccines/virus
  • Track 12-3Novel vaccines
  • Track 12-4Human vaccines
  • Track 12-5HIV/AIDS vaccines
  • Track 12-6HPV vaccines
  • Track 12-7Therapeutic vaccination for auto immune diseases
  • Track 12-8New vaccines
  • Track 12-9Veterinary vaccines

In this session we will focus on medical devices designed for drug delivery conferences through the pulmonary and nasal routes. These routes are of interest for local delivery, as in asthma, but also for rapid delivery of drugs to the system circulation and direct delivery to the central nervous system. Devices that account for specific anatomical and physiological features of the intranasal and pulmonary routes will be featured. Drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a specific route of administration. Such devices are used as part of one or more medical treatments. Many in the industry have long felt overly burdened by what they consider to be an unnecessarily complex approval process. Critics claim it impedes innovation and delays the availability of better health care. In order to help innovators bring health care to the public Pharmaceutica 2019 hosts drug delivery conferences throughout the year.

For more information visit: Pharmaceutical Conferences

 

  • Track 13-1Biomedical instrumentation measurements
  • Track 13-2Positron-emission tomographic (PET) scanning
  • Track 13-3Computed tomographic scanning (CT scanning)
  • Track 13-4Ultrasonography
  • Track 13-5Ophthalmic and ENT instruments
  • Track 13-6Instrumentation for the medical use of radioisotopes
  • Track 13-7Quality by design (QBD)
  • Track 13-8Pacemakers and defibrillators
  • Track 13-9Respiratory therapy equipment
  • Track 13-10Instrumentation for the experimental analysis of behavior
  • Track 13-11Instrumentation for psychophysiological measurements
  • Track 13-12Measurement of blood flow and cardiac output
  • Track 13-13Magnetic resonance imaging

Biologics are medicines made from living cells through highly complex manufacturing processes and must be handled and administered under carefully monitored conditions. Biologics are used to prevent, treat, diagnose, or cure a variety of diseases including cancer, chronic kidney disease, autoimmune disorders, and infectious diseases. Euro Biosimilars is exactly what its name implies — it is a biologic that is “similar” to another biologic drug already approved by the FDA. Under U.S. law, a biosimilar is approved based on a showing that it is “highly similar” to an FDA-approved biological product, known as a reference product. It may not have any clinically meaningful differences in terms of safety and effectiveness from the reference product.

For more information visit: Pharmaceutical Conferences

 

  • Track 14-1Bio-analytics for biosimilars
  • Track 14-2Extrapolation and interchangeability
  • Track 14-3Legal considerations for biosimilars
  • Track 14-4Biosimilar uptake and market considerations
  • Track 14-5Challenges and regulatory approach for biosimilars
  • Track 14-6Future of next generation biosimilars

Pharmaceutical analysis 2018 is a process or a sequence of processes to identify and/or quantify a substance or drug, the components of a pharmaceutical solution or mixture or the determination of the structures of chemical compounds used in the formulations 2018 of pharmaceutical product. Analytical techniques conferences mainly used for the separation of the components from the mixture and for the determination of the structure of the compounds.

For more information visit: Pharmaceutical Conferences

 

  • Track 15-1Novel approaches to analytical and bioanalytical methods
  • Track 15-2Bioanalytical techniques
  • Track 15-3Chromatography and techniques
  • Track 15-4Spectroscopic techniques
  • Track 15-5Nuclear magnetic resonance
  • Track 15-6Mass spectroscopy
  • Track 15-7Regulatory issues and biosafety challenges in bioanalysis
  • Track 15-8Applications of analytical and bioanalytical methods

Quality is always an imperative prerequisite when we consider any product. Therefore, drugs must be manufactured to the highest quality levels. End-product testing by itself does not guarantee the quality of the product. Quality assurance techniques must be used to build the quality into the product at every step and not just tested for at the end. In pharmaceutical industry 2019, Process Validation performs this task to build the quality into the product because according to ISO 9000:2000, it had proven to be an important tool for quality management of pharmaceuticals. Validation is one of the important steps in achieving and maintaining the quality of the final product. If each step of production process is validated we can assure that the final product is of the best quality. Validation of the individual steps of the processes is called the process validation. Different dosage forms have different validation protocols. Process Validation is one of the important steps in achieving and maintaining the quality of final product. It gives a higher degree of assurance.

For more information visit: Pharmaceutical Conferences

 

  • Track 16-1Process validation and drug quality
  • Track 16-2Approach to process validation
  • Track 16-3Statutory and regulatory requirements for process validation
  • Track 16-4Types of process validation
  • Track 16-5Validation protocol and report

Packaging is one of the largest industry sectors in the world, worth several billions. Pharmaceutical packaging represents a meager percentage of this colossal market. The global healthcare industry has seen a shift in paradigm and is now skewed toward effective and meaningful packaging. Packaging was considered as an afterthought which was required merely in the final stages of manufacturing for many pharmaceutical companies about a decade ago.

For more information visit: Pharmaceutical Conferences

 

  • Track 17-1Future of packaging materials
  • Track 17-2Regulatory considerations-China, US, EU, Pharmacopoeia
  • Track 17-3Packaging for patient compliance
  • Track 17-4Serialization implementation challenges for pharma companies
  • Track 17-5EN 16679-anti-counterfeiting and tamper evidence techniques
  • Track 17-6Packing technology for drug delivery systems

Clinical research 2018 aims to advance medical knowledge by studying people, either through direct interaction or through the collection and analysis of blood, tissues, or other samples.

A clinical trial involves research participants. It follows a pre-defined plan or protocol to evaluate the effects of a medical or behavioral intervention on health outcomes. By taking part in clinical trials conferences, participants not only play a more active role in their own health care, but they also can access experimental treatments and help others by contributing to medical research.

For more information visit: Pharmaceutical Conferences

 

  • Track 18-1Clinical research & clinical trials: Academic perspective
  • Track 18-2Clinical trial forecasting, budgeting and contracting
  • Track 18-3Clinical trial site selection and management
  • Track 18-4CRO, sponsorship & outsourcing for clinical trials
  • Track 18-5Future of clinical trials and technology innovations
  • Track 18-6Clinical data management and analytics
  • Track 18-7Medical imaging in clinical research
  • Track 18-8Clinical trials on different diseases
  • Track 18-9Research and trials on Oncology and Aids
  • Track 18-10Innovations in clinical study designs
  • Track 18-11Patient-centric clinical trials
  • Track 18-12Clinical operations & project management
  • Track 18-13Clinical supply management

Pharmacogenetics is the science that supports understanding the part that a person's hereditary make-up plays in how well a prescription functions, and additionally what symptoms are probably going to happen, enhancing our capacity to distinguish the hereditary reasons for illnesses and look for new medication targets. Pharmacogenetics alludes to hereditary contrasts in metabolic pathways which can influence singular reactions to drugs, both as far as restorative impact and additionally antagonistic impacts.

Pharmacogenomics is a quickly creating field that has essential ramifications in individualized treatment for patients and its suggestion influence tranquilize advancement issues such as medication safety, efficiency, and customized health care. Pharmacogenomics consolidates customary pharmaceutical sciences 2019, for example, natural chemistry with explained colleague of qualities, proteins, and single nucleotide polymorphisms.

For more information visit: Pharmaceutical Conferences

  • Track 19-1Cancer pharmcogenetics
  • Track 19-2Recent advances in DNA repair
  • Track 19-3Methods to determine biological targeting
  • Track 19-4T cell modulation and immune response
  • Track 19-5Mutagenecity and genotoxicity

Regulatory Affairs conferences contribute essentially to the overall success of drug development, both at early pre-marketing stages and at all times post-marketing. The pharmaceutical industry 2019 deals with an increasing number of interesting drug candidates, all of which necessitate the involvement of the quality assurance in regulatory affairs department.  The importance of intellectual property law is well established at all levels-statutory, administrative and judicial. It lays down minimum standards for protection and enforcement in member countries which are required to promote effective and adequate protection of intellectual property rights with a view to reducing distortions and impediments to international trade. The Agreement provides norms and standards in respect of following areas of intellectual properties are Patents, Trademarks, copyrights, Geographical indications, Industrial designs.

For more information visit: Pharmaceutical Conferences

 

  • Track 20-1Drug regulations and organizations
  • Track 20-2Global pharma products registration
  • Track 20-3Intellectual property law for generics and innovator rights

Industrial pharmacy is a discipline which includes manufacturing, development, marketing and distribution of drug products including quality assurance of these activities. The research topics are focused on solving current general problems in pharmaceutical industry conferences, such as formulation 2018 and characterization of sticky amorphous drugs, problem-solving for paediatric medicines and miniaturization of manufacturing processes.

Physical pharmacy conferences incorporate information of arithmetic, material science and science and apply them to the pharmaceutical dose frame improvement. Physical pharmacy gives the premise to understanding the synthetic and physical wonders that oversee the in vivo and in vitro activities of pharmaceutical items.

For more information visit: Pharmaceutical Conferences

  • Track 21-1Product management
  • Track 21-2Physical pharmacy practice
  • Track 21-3Post- marketing surveillance
  • Track 21-4Supply chain management
  • Track 21-5Good manufacturing practices
  • Track 21-6Industrial pharmaceutics

Clinical pharmacy is a health science discipline in which pharmacists provide patient care that optimizes medication therapy and promotes health, and disease prevention. The practice of clinical pharmacy conferences embraces the philosophy of pharmaceutical care, blending a caring orientation with specialized therapeutic knowledge, experience, and judgment to ensure optimal patient outcomes. As a discipline, clinical pharmacy also has an obligation to contribute to the generation of new knowledge that advances health and quality of life.

Hospital pharmacy is a specialization of this field that includes additional duties such as aiding doctors in applying drug therapy. The statements were developed by the profession to bring uniformity to the practice of hospital pharmacy.

For more information visit: Pharmaceutical Conferences

 

  • Track 22-1Pharmacist key role in treatment
  • Track 22-2Role of clinical pharmacist
  • Track 22-3Challenges in compounding and dispensing pharmacy
  • Track 22-4Role of hospital pharmacists

Pharmacovigilance is the science and exercises identifying with the discovery, evaluation, comprehension and counteractive action of unfavorable impacts or some other pharmaceutical related issue. Pharmacovigilance Conferences  underpins general wellbeing programs by giving solid data to the productive evaluation of the hazard advantage profile of solutions, add to the appraisal of formal, uses, symptoms, damage, viability and danger of pharmaceuticals, empowering the sheltered, sound and more viable utilization of different medications. Advance instruction, understanding and clinical preparing in Pharmacovigilance and its successful accessibility to people in general.

Drug safety is otherwise called Medication Safety in the field of health. It is related with antagonistic impacts of Pharmaceutical items including numerous other logical perspectives, for example, the reactions of medications, the nature of solutions, prescription mistake in utilization of medications, absence of viability of medications, and fake medications. Tolerant Safety, Drug Interaction (drug–drug and food–drug cooperation) Drug Pharmacokinetic, and Adverse Drug Reaction are a few terms required with Drug Safety.

For more information visit: Pharmaceutical Conferences

 

  • Track 23-1Postmarketing drug safety
  • Track 23-2Signal detection in drug safety
  • Track 23-3Consulting on risk management
  • Track 23-4Adverse event reporting

Standards of initial education and training for pharmacists set out the criteria against which we will approve education and training for student pharmacists and pre-registration trainee pharmacists. The standards ensure that newly registered pharmacists are competent to practice safely and effectively. The mission of pharmacy education is to prepare graduates who provide patient centered care that ensures optimal medication therapy outcomes and provides a foundation for specialization in specific areas of pharmacy practice; to participate in the education of patients, other health care providers and future pharmacists, to conduct research and scholarly activity and to provide service and leadership to the community.

For more information visit: Pharmaceutical Conferences

 

  • Track 24-1Clinical practice guidelines
  • Track 24-2Patient centered pharmacy practice
  • Track 24-3Global technical standards
  • Track 24-4Critical view of pharmacy education